Red de Bibliotecas Virtuales de Ciencias Sociales en
América Latina y el Caribe

logo CLACSO

Por favor, use este identificador para citar o enlazar este ítem: https://biblioteca-repositorio.clacso.edu.ar/handle/CLACSO/169298
Título : Added value of an anti-Ebola serology for the management of clinically suspected Ebola virus disease patients discharged as negative in an epidemic context
Palabras clave : DRC;Ebola;Ituri;North-Kivu;serology
Descripción : Background Survivors from Ebola virus disease (EVD) may be at the origin of EVD resurgence. Methods Simultaneous reactivity to at least 2 Ebola virus or Zaire ebolavirus (EBOV) antigens was detected in 11 of 488 (2.3%; 95% confidence interval [CI], 1.1-4.0) suspected EVD patients who were discharged as negative after 2 consecutive negative tests during the 10th Ebola outbreak in the Democratic Republic of the Congo. Results After extrapolating the total number of individuals discharged as negative during the entire outbreak, we estimated a total of 1314 additional missed Ebola cases. Conclusions These findings emphasize the usefulness of an EBOV serology analysis and the importance of extending epidemic surveillance to clinically suspected cases who were discharged as negative. In clinically suspected EVD patients, EVD may be missed and inadvertently cause EBOV resurgence. Thus, surveillance during and after outbreaks should be extended to EBOV household contacts and to patients discharged as negative with an accurate serologic assay.
URI : https://biblioteca-repositorio.clacso.edu.ar/handle/CLACSO/169298
Otros identificadores : https://www.documentation.ird.fr/hor/fdi:010084575
oai:ird.fr:fdi:010084575
Nkuba-Ndaye A., Mukadi-Bamuleka D., Bulabula-Penge J., Thaurignac G., Edidi-Atani F., Mambu-Mbika F., Danga-Yema B., Matondo-Kuamfumu M., Kinganda-Lusamaki E., Bisento N., Lumembe-Numbi R., Kabamba-Lungenyi G., Kitsa-Mutsumbirwa D., Kambale-Sivihwa N., Boillot F., Delaporte E., Mbala-Kingebeni P., Ayouba Ahidjo, Peeters Martine, Ahuka-Mundeke S.. Added value of an anti-Ebola serology for the management of clinically suspected Ebola virus disease patients discharged as negative in an epidemic context. 2022, [Early access], p. [5 p.]
Aparece en las colecciones: IRD - Cosecha

Ficheros en este ítem:
No hay ficheros asociados a este ítem.


Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.